Skip to main content

CRISPR Stocks Rise After Chinese Researcher Claims First Gene-Edited Babies

Shares of Crispr Therapeutics, Editas Medicine and Intellia Therapeutics are on the rise after a Chinese researcher claimed that he helped make the world's first genetically edited babies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.